Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose dutasteride effectively and safely promotes hair growth in men.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

SER120 nasal spray effectively reduces nighttime urination and is safe for patients.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Clascoterone 1% cream is a promising new treatment for acne.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Vedistry Amla + Tablets improve hair health and are safe to use.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Topical JAK inhibitors may help treat some skin conditions but need more research.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

The treatment was ineffective in humans.

Botulinum toxin affects hair follicles, inhibiting TGF-B1 secretion; more research ongoing.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Dutasteride is a safe and effective treatment for hair loss.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.